| Literature DB >> 23585982 |
Anna E Maciag1, Ryan J Holland, Joseph E Saavedra, Harinath Chakrapani, Paul J Shami, Larry K Keefer.
Abstract
Promising drug candidates of the diazeniumdiolate (NONOate) chemical family include several types of thiol modification among their mechanisms of action: 1) drugs designed to release nitric oxide (NO) on reaction with the thiol group of glutathione (GSH) arylate the GSH, a step that removes reducing equivalents from the cell; (2) a similar reaction of the drug with the thiol group of a protein changes its structure, leading to potentially impaired function and cell death; (3) the NO generated as a byproduct in the above reactions can undergo oxidation, leading to S-nitrosylation and S-glutathionylation; and (4) diazeniumdiolates can also generate nitroxyl, which reacts with thiol groups to form disulfides or sulfinamides.Entities:
Keywords: diazeniumdiolate; nitric oxide; thiol
Year: 2012 PMID: 23585982 PMCID: PMC3622254 DOI: 10.1615/ForumImmunDisTher.2012006334
Source DB: PubMed Journal: For Immunopathol Dis Therap ISSN: 2151-8017